Sandbox carlos: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) mNo edit summary |
Gerald Chi- (talk | contribs) mNo edit summary |
||
Line 1: | Line 1: | ||
{{PBI| | {{PBI|Cystoisospora belli}} | ||
:* 1. '''Cystoisospora belli treatment''' | |||
:* 2. '''Cystoisospora belli prophylaxis''' | |||
::* 2.1 '''Primary prophylaxis''' | |||
::* 2.2 '''Secondary prophylaxis (preventing recurrence in patients with CD4 count < 200 cells/mm<sup>3</sup>)''' | |||
:::* Prefered regimen: [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO 3 times weekly | |||
:::* Alternative regimen (1): [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO qd | |||
:::* Alternative regimen (2): [[Trimethoprim-sulfamethoxazole]] 320 mg/1600 mg PO 3 times weekly | |||
:::* Alternative regimen (3): [[Pyrimethamine]] 25 mg PO qd {{and}} [[Leucovorin]] 5–10 mg PO qd | |||
:::* Alternative regimen (4): [[Ciprofloxacin]] 500 mg PO 3 times weekly | |||
:::* Note: Criteria for discontinuation of chronic maintenance therapy: sustained increase in CD4 count > 200 cells/mm<sup>3</sup> for > 6 months in response to ART and without evidence of active Cystoisospora belli infection | |||
---- | |||
:*'''Immunocompetent'''<ref name=CDC Parasites - Cystoisosporiasis>{{cite web | title = CDC - Cystoisosporiasis| url = http://www.cdc.gov/parasites/cystoisospora/health_professionals/index.html }}</ref> | :*'''Immunocompetent'''<ref name=CDC Parasites - Cystoisosporiasis>{{cite web | title = CDC - Cystoisosporiasis| url = http://www.cdc.gov/parasites/cystoisospora/health_professionals/index.html }}</ref> | ||
::* Prefered regimen: [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO {{or}} IV qid for 10 days | ::* Prefered regimen: [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO {{or}} IV qid for 10 days |
Revision as of 17:56, 16 July 2015
- Cystoisospora belli
Return to Top
- 1. Cystoisospora belli treatment
- 2. Cystoisospora belli prophylaxis
- 2.1 Primary prophylaxis
- 2.2 Secondary prophylaxis (preventing recurrence in patients with CD4 count < 200 cells/mm3)
- Prefered regimen: Trimethoprim-sulfamethoxazole 160 mg/800 mg PO 3 times weekly
- Alternative regimen (1): Trimethoprim-sulfamethoxazole 160 mg/800 mg PO qd
- Alternative regimen (2): Trimethoprim-sulfamethoxazole 320 mg/1600 mg PO 3 times weekly
- Alternative regimen (3): Pyrimethamine 25 mg PO qd AND Leucovorin 5–10 mg PO qd
- Alternative regimen (4): Ciprofloxacin 500 mg PO 3 times weekly
- Note: Criteria for discontinuation of chronic maintenance therapy: sustained increase in CD4 count > 200 cells/mm3 for > 6 months in response to ART and without evidence of active Cystoisospora belli infection
- Immunocompetent
- Prefered regimen: Trimethoprim-sulfamethoxazole 160 mg/800 mg PO OR IV qid for 10 days
- 1. Patients with sulfa intolerance
- Alternative regimen (1): Pyrimethamine 50-75 mg PO daily AND Leucovorin 10–25 mg PO daily
- Alternative regimen (2): Ciprofloxacin 500 mg PO BID for 7 days
- HIV
- 1. Patients with CD4 Count <200/mm3 (chronic treatment)
- Prefered regimen: Trimethoprim-sulfamethoxazole 160 mg/800 mg PO 3 times weekly
- Alternative regimen (1): Trimethoprim-sulfamethoxazole 320 mg/1600 mg PO 3 times weekly
- Alternative regimen (2): Pyrimethamine 25 mg PO daily AND Leucovorin 5–10 mg PO daily
- Alternative regimen (3): Ciprofloxacin 500 mg PO 3 times weekly